← Leaderboards
Clifford Berkman
San Francisco State University
$4,858,855
Attributed
$5,269,075
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $816.3K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,269,075 · 10
By mechanism
R21$3,430,392 · 9
R01$1,838,683 · 1
Top collaborators
- Leslie Ann Caromile3 shared
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageBaseTherapeutic AgentsSmall MoleculeAffinityTechnologyEnzymesIn VivoInhibitor/AntagonistScaffoldTumorMalignant Neoplasm Of ProstateAchievementCellsEndotheliumPositron-Emission TomographyInnovationMalignant NeoplasmsDyesDiagnosticIn VitroNeovasculatureNovel TherapeuticsAntigen Targeting
Grant awards (20)
Frontiers in Bone Metastatic Models for Prostate Cancer$422,874
R21 · FY2024 · CA
Tumor-Activated Dual Payload-Drug Conjugates$393,401
R21 · FY2024 · CA · contact PI
Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors$172,722
R21 · FY2022 · CA · contact PI
Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors$224,845
R21 · FY2021 · CA · contact PI
PSMA - Targeted Small-Molecule Drug Conjugates$175,809
R21 · FY2019 · CA · contact PI
PSMA - Targeted Small-Molecule Drug Conjugates$199,665
R21 · FY2018 · CA · contact PI
MMP-14 Chimeric Ligands for Targeted Imaging of Metastatic Tumors$196,267
R21 · FY2016 · CA · contact PI
Inactivating Inhibitors of Mycobacterium tuberculosis beta-lactamase BlaC$188,750
R21 · FY2016 · AI · contact PI
Inactivating Inhibitors of Mycobacterium tuberculosis beta-lactamase BlaC$226,500
R21 · FY2015 · AI · contact PI
MMP-14 Chimeric Ligands for Targeted Imaging of Metastatic Tumors$164,213
R21 · FY2015 · CA · contact PI
Probe Optimization for Prostate Cancer Detection$419,835
R01 · FY2013 · CA · contact PI
Development of a Malarial Kinase-on-Phage Screening Platform$177,425
R21 · FY2013 · AI · contact PI
Probe Optimization for Prostate Cancer Detection$459,037
R01 · FY2012 · CA · contact PI
Development of a Malarial Kinase-on-Phage Screening Platform$218,850
R21 · FY2012 · AI · contact PI
Probe Optimization for Prostate Cancer Detection$462,741
R01 · FY2011 · CA · contact PI
Probe Optimization for Prostate Cancer Detection$497,070
R01 · FY2010 · CA · contact PI
Chemoaffinity Agents For Capturing Prostate Cancer Cells$162,581
R21 · FY2009 · CA · contact PI
Chemoaffinity Agents For Capturing Prostate Cancer Cells$195,098
R21 · FY2008 · CA · contact PI
Inhibitor-Directed Imaging of Prostate Cancer$195,112
R21 · FY2007 · CA · contact PI
Inhibitor-Directed Imaging of Prostate Cancer$116,280
R21 · FY2006 · CA · contact PI